Log in
NYSE:WEI

Weidai Stock Forecast, Price & News

$2.04
+0.30 (+17.24 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.96
Now: $2.04
$2.74
50-Day Range
$0.82
MA: $1.57
$5.13
52-Week Range
$0.73
Now: $2.04
$6.08
Volume35.02 million shs
Average Volume1.52 million shs
Market Capitalization$143.71 million
P/E Ratio3.92
Dividend YieldN/A
Beta1.11
Weidai Ltd., through its subsidiaries, provides auto-backed financing solutions in the People's Republic of China. Its auto-backed financing platform connects borrowers primarily small and micro enterprise owners with online investors and institutional funding partners. The company was founded in 2011 and is headquartered in Hangzhou, the People's Republic of China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.94 out of 5 stars


Industry, Sector and Symbol

Industry Nondepository credit institutions
Sub-IndustryN/A
SectorFinance
CUSIPN/A
CIKN/A
Phone86-571-5697-9013
Employees6,970

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$482.27 million
Cash Flow$1.50 per share
Book Value$4.64 per share

Profitability

Miscellaneous

Market Cap$143.71 million
Next Earnings Date12/29/2020 (Estimated)
OptionableNot Optionable
$2.04
+0.30 (+17.24 %)
(As of 11/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive WEI News and Ratings via Email

Sign-up to receive the latest news and ratings for WEI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Weidai (NYSE:WEI) Frequently Asked Questions

How has Weidai's stock price been impacted by Coronavirus (COVID-19)?

Weidai's stock was trading at $1.46 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, WEI shares have increased by 39.7% and is now trading at $2.04.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Weidai?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Weidai in the last year. There are currently 1 sell rating for the stock, resulting in a consensus recommendation of "Sell."
View analyst ratings for Weidai
.

What stocks does MarketBeat like better than Weidai?

Wall Street analysts have given Weidai a "Sell" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Weidai wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Weidai's next earnings date?

Weidai is scheduled to release its next quarterly earnings announcement on Tuesday, December 29th 2020.
View our earnings forecast for Weidai
.

How were Weidai's earnings last quarter?

Weidai Ltd. (NYSE:WEI) announced its quarterly earnings data on Wednesday, May, 27th. The company reported ($1.14) earnings per share (EPS) for the quarter, missing the consensus estimate of $1.55 by $2.69. The business earned $101.54 million during the quarter.
View Weidai's earnings history
.

Are investors shorting Weidai?

Weidai saw a increase in short interest during the month of October. As of October 30th, there was short interest totaling 382,600 shares, an increase of 4,348.8% from the October 15th total of 8,600 shares. Based on an average trading volume of 4,190,000 shares, the days-to-cover ratio is currently 0.1 days.
View Weidai's Short Interest
.

Who are some of Weidai's key competitors?

What other stocks do shareholders of Weidai own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Weidai investors own include AbbVie (ABBV), Carnival Co. & (CCL), Energy Transfer (ET), American Airlines Group (AAL), Baidu (BIDU), Corbus Pharmaceuticals (CRBP), NIO (NIO), Ovid Therapeutics (OVID), Primo Water (PRMW) and Voyager Therapeutics (VYGR).

Who are Weidai's key executives?

Weidai's management team includes the following people:
  • Mr. Yao Hong, Founder, Chairman & CEO (Age 40)
  • Mr. Chen Feng, Pres, CFO & Director (Age 44)
  • Mr. Zhu Jianzhong, VP of Technology, R&D (Age 41)
  • Mr. Wang Pengfei, VP of Brand Devel., Strategy & Compliance (Age 38)
  • Mr. Ding Desheng, VP of Fin. & Risk Management, Chief Risk Officer and Director (Age 38)

When did Weidai IPO?

(WEI) raised $45 million in an initial public offering on Thursday, November 15th 2018. The company issued 4,500,000 shares at a price of $9.00-$11.00 per share. Morgan Stanley and Citigroup served as the underwriters for the IPO and AMTD was co-manager.

What is Weidai's stock symbol?

Weidai trades on the New York Stock Exchange (NYSE) under the ticker symbol "WEI."

How do I buy shares of Weidai?

Shares of WEI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Weidai's stock price today?

One share of WEI stock can currently be purchased for approximately $2.04.

How big of a company is Weidai?

Weidai has a market capitalization of $143.71 million and generates $482.27 million in revenue each year. The company earns $36.43 million in net income (profit) each year or $0.52 on an earnings per share basis. Weidai employs 6,970 workers across the globe.

What is Weidai's official website?

The official website for Weidai is www.weidai.com.cn.

How can I contact Weidai?

Weidai's mailing address is NO. 9 BAIYUN ROAD SHANGCHENG DISTRICT, HANGZHOU F4, 310000. The company can be reached via phone at 86-571-5697-9013 or via email at [email protected]

This page was last updated on 11/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.